ClinicalTrials.Veeva

Menu

PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)

G

Guidant

Status and phase

Completed
Phase 2

Conditions

Acute Myocardial Infarction

Treatments

Device: Temporary RV VVI pacing

Study type

Interventional

Funder types

Industry

Identifiers

NCT00409604
CS1017-001

Details and patient eligibility

About

To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction

Full description

To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of acute myocardial infarction, requiring PCI within 2 to 6 hours following symptoms
  • Total occlusion of a coronary artery with reference vessel diameter >or= 3mm

Exclusion criteria

  • Thrombolitics
  • Severe bradycardia requiring cardiac pacing
  • Previous PCI or CABG
  • Recent stroke or CV surgery
  • Recent major surgery or trauma
  • Clinical and hemodynamic unstability
  • Implanted CRM device
  • Evidence of previous MI
  • Diabetes using rosiglitazone or other fibrates
  • Permanent AF
  • Mechanical tricuspid valve
  • Pregnancy
  • Exclusion for MRI
  • Incapability of participating in exercise test

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

1
Experimental group
Description:
Standard PCI procedure + pacing post conditioning
Treatment:
Device: Temporary RV VVI pacing
2
No Intervention group
Description:
Standard PCI procedure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems